Meghan McCain announced on Wednesday that she had partnered with a "detox" product for people who "regret taking" the ...

The US Department of Health and Human Services will not extend a grant funding the Center for HIV/AIDS Vaccine Development, ...

TriLink BioTechnologies®, a division of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI ), announced a non-exclusive ...

Alnylam Pharmaceuticals Inc. won’t get another chance at its patent infringement suit against Moderna Inc. over its mRNA Covid-19 vaccine, a federal appeals court ruled Wednesday.

Downstream processing for mRNA manufacturing is currently too complex, but simplifying by using precipitation looks promising.

Alzheimer's disease is the most common cause of dementia and affects more than a tenth of Americans aged 65 and older. The ...

The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...

In a precedential decision issued June 4, 2025, the U.S. Court of Appeals for the Federal Circuit (CAFC) affirmed a district ...

In this week’s edition of InnovationRx, we look at the impact of Trump’s proposed budget cuts on biomedical research and ...

Duke University says it’s “an enormous setback” for creating a vaccine to fight the cause of AIDS. The Trump administration ...

Moderna had already started a Phase 1/2 trial of its bird flu (H5N1) vaccine and reported strong early results.

HHS Secretary Robert F. Kennedy Jr. says Moderna (MRNA) has agreed to do another clinical trial to back its newly approved ...